Accession Number: | 0001104659-20-034208 |
Date: | 2020-03-13 |
Issuer: | AKERO THERAPEUTICS, INC. (AKRO) |
Original Submission Date: |
YOUNG JONATHAN
C/O AKERO THERAPEUTICS,
INC., 170 HARBOR WAY, 3RD FLOOR
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-03-13 | M | 5,035 | a | $0.62 | 177,518 | direct | ||
COMMON STOCK | 2020-03-13 | M | 6,082 | a | $0.62 | 183,600 | direct | ||
COMMON STOCK | 2020-03-13 | 0 | $0.00 | 20,000 | indirect | f2 | |||
COMMON STOCK | 2020-03-13 | 0 | $0.00 | 20,000 | indirect | f2 | |||
COMMON STOCK | 2020-03-13 | 0 | $0.00 | 20,000 | indirect | f2 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.615 | 2020-03-13 | deemed execution date | M | 5,035 (d) | 2028-07-29 | common stock 5,035 | $0.62 | 42,796 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 0.615 | 2020-03-13 | deemed execution date | M | 6,082 (d) | 2028-10-17 | common stock 6,082 | $0.62 | 94,268 | direct |
ID | footnote |
---|---|
f1 | due to a clerical error in the preparation of the reporting person's form 3, the reporting person's beneficial ownership was overstated by 60,000 on the form 3 filed on june 19, 2019 and the form 4s filed on december 31, 2019 and january 10, 2019 as the 60,000 shares that are indicated as being owned by the ea irrevocable trust, cm irrevocable trust and jl irrevocable trust were not removed from the reporting person's direct ownership total reported in column 5. that error has been corrected in this form 4. |
f2 | these shares are held in irrevocable trusts for the benefit of the reporting person's children. the reporting person's spouse is trustee of the trusts. the reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of section 16 or for any other purpose. |
f3 | 25% of this option vested on august 1, 2018 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter. |
f4 | shares vested and became exercisable in equal monthly installments for a period of 48 months following october 1, 2018. |